| Envoy Of Alexandria, Llc | |
| 900 Virginia Avenue, Alexandria, Virginia 22302 | |
| (703) 684-9100 | |
| Name | Envoy Of Alexandria, Llc |
|---|---|
| Location | 900 Virginia Avenue, Alexandria, Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 111 |
| Occupancy Rate | 81.08% |
| Medicare ID (CCN) | 495203 |
| Legal Business Name | Envoy Of Alexandria, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1306099429 |
| Organization Name | ENVOY OF ALEXANDRIA, LLC |
| Address | 900 Virginia Ave, Alexandria, VA 22302 |
| Phone Number | 703-684-9100 |
News Archive
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not show improvements in the trial's primary endpoint, the rate of cardiovascular death, subsequent heart attack or urgent coronary revascularization, which includes placement of a stent or coronary artery bypass surgery, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
Kaiser Health News reports that advocates of the health law, which is under renewed attack by Republicans after the mid-term election, are "huddling … in an effort to thwart GOP efforts" to overturn the law. "Groups that back the law aren't likely to coalesce around a single message to increase public support. Some patient groups, for example, are likely to try to steer clear of partisan politics and focus instead on promoting the law and pressing for its full implementation.
› Verified 1 days ago
| NPI Number | 1568412831 |
| Organization Name | RUXTON HEALTH CARE VI, LLC |
| Doing Business As | RUXTON HEALTH OF ALEXANDRIA |
| Address | 900 Virginia Ave, Alexandria, VA 22302 |
| Phone Number | 703-684-9100 |
News Archive
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not show improvements in the trial's primary endpoint, the rate of cardiovascular death, subsequent heart attack or urgent coronary revascularization, which includes placement of a stent or coronary artery bypass surgery, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
Kaiser Health News reports that advocates of the health law, which is under renewed attack by Republicans after the mid-term election, are "huddling … in an effort to thwart GOP efforts" to overturn the law. "Groups that back the law aren't likely to coalesce around a single message to increase public support. Some patient groups, for example, are likely to try to steer clear of partisan politics and focus instead on promoting the law and pressing for its full implementation.
› Verified 1 days ago
| NPI Number | 1780304055 |
| Organization Name | ALEXANDRIA OPERATOR LLC |
| Doing Business As | ALEXANDRIA REHABILITATION AND HEALTHCARE CENTER |
| Address | 900 Virginia Ave, Alexandria, VA 22302 |
| Phone Number | 703-684-9100 |
News Archive
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not show improvements in the trial's primary endpoint, the rate of cardiovascular death, subsequent heart attack or urgent coronary revascularization, which includes placement of a stent or coronary artery bypass surgery, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
Kaiser Health News reports that advocates of the health law, which is under renewed attack by Republicans after the mid-term election, are "huddling … in an effort to thwart GOP efforts" to overturn the law. "Groups that back the law aren't likely to coalesce around a single message to increase public support. Some patient groups, for example, are likely to try to steer clear of partisan politics and focus instead on promoting the law and pressing for its full implementation.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not show improvements in the trial's primary endpoint, the rate of cardiovascular death, subsequent heart attack or urgent coronary revascularization, which includes placement of a stent or coronary artery bypass surgery, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
Kaiser Health News reports that advocates of the health law, which is under renewed attack by Republicans after the mid-term election, are "huddling … in an effort to thwart GOP efforts" to overturn the law. "Groups that back the law aren't likely to coalesce around a single message to increase public support. Some patient groups, for example, are likely to try to steer clear of partisan politics and focus instead on promoting the law and pressing for its full implementation.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.15 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.84 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.87 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.8 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.4 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.19 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.04 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.41 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.25 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.55 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 99.02 | 82.93 |
News Archive
Patients taking losmapimod, an anti-inflammatory drug currently being developed, for 12 weeks following a heart attack did not show improvements in the trial's primary endpoint, the rate of cardiovascular death, subsequent heart attack or urgent coronary revascularization, which includes placement of a stent or coronary artery bypass surgery, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Beginning this month, all patients undergoing cardiac catheterization at Vanderbilt University Medical Center will be tested for a genetic variation that can affect their response to Plavix, the most commonly prescribed clot-preventing drug for heart patients and one of the most commonly prescribed drugs worldwide.
Kaiser Health News reports that advocates of the health law, which is under renewed attack by Republicans after the mid-term election, are "huddling … in an effort to thwart GOP efforts" to overturn the law. "Groups that back the law aren't likely to coalesce around a single message to increase public support. Some patient groups, for example, are likely to try to steer clear of partisan politics and focus instead on promoting the law and pressing for its full implementation.
› Verified 1 days ago
Manorcare Health Services-alexandria Location: 1510 Collingwood Road, Alexandria, Virginia 22308 Phone: (703) 765-6107 | |
Woodbine Rehabilitation & Healthcare Center Location: 2729 King St, Alexandria, Virginia 22302 Phone: (703) 836-8838 | |
Goodwin House Alexandria Location: 4800 Fillmore Ave, Alexandria, Virginia 22311 Phone: (703) 824-1192 | |
Envoy Of Alexandria, Llc Location: 900 Virginia Avenue, Alexandria, Virginia 22302 Phone: (703) 684-9100 | |
Mount Vernon Healthcare Center Location: 8111 Tiswell Drive, Alexandria, Virginia 22306 Phone: (703) 360-4000 | |
The Fountains At Washington House Location: 5100 Fillmore Avenue, Alexandria, Virginia 22311 Phone: (703) 845-5000 |